Clinical Trial Update: Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating sequencing of stereotactic ablative body radiotherapy with pembrolizumab in metastatic non-small cell lung cancer has been terminated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Keytruda (Pembrolizumab) (pembrolizumab)

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Non-small Cell Lung Cancer | Phase 1 | Status: TERMINATED | Results posted: 2025-09-15